NCT06063070
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer treatment 2 not_yet_recruiting NCT01767675
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 active_not_recruiting NCT01223235
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab treatment Not Available completed NCT03030287
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer treatment 1 completed NCT03759587
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer treatment 2 completed NCT00870233
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life No drug interventions Not Available Not Available completed NCT03056833
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer treatment 1 completed NCT05220033
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer No drug interventions supportive_care Not Available recruiting NCT04402333
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival No drug interventions Not Available Not Available unknown_status NCT01281254
AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) treatment 3 terminated NCT05792254
Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer No drug interventions treatment Not Available not_yet_recruiting NCT00369954
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin treatment 2 withdrawn NCT01220154
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer treatment 1 unknown_status NCT05287451
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study No drug interventions prevention Not Available recruiting NCT05274451
A Study to Investigate LYL797 in Adults with Solid Tumors No drug interventions treatment 1 recruiting NCT03771651
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube treatment 0 active_not_recruiting NCT00066651
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01442051
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer No drug interventions treatment Not Available completed NCT04991051
Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer No drug interventions Not Available Not Available completed NCT03604653
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers Not Available Not Available completed NCT04295577
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR No drug interventions Not Available Not Available unknown_status NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors treatment 1 recruiting NCT00022347
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 completed NCT04516447
A Study of ZN-c3 in Patients With Ovarian Cancer treatment 1 recruiting NCT00003345
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT04701645
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer No drug interventions diagnostic 1 recruiting NCT00295945
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer Not Available Not Available completed NCT05446298
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer treatment 2 recruiting NCT02606305
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 completed NCT00582205
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma treatment 2 terminated NCT00045461
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 2 / 3 unknown_status NCT00019461
Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT02824328
A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers No drug interventions Not Available Not Available completed NCT00653328
Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma treatment 2 terminated NCT00382811
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer treatment 3 completed NCT06290193
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Primary Cytoreductive Surgery No drug interventions treatment 2 recruiting NCT00096993
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT00334893
Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer treatment 2 completed NCT05281471
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) treatment 3 recruiting NCT00098878
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT05445778
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) treatment 3 recruiting NCT02759588
GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer No drug interventions treatment 1 / 2 completed NCT06024109
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy No drug interventions Not Available Not Available recruiting NCT04029909
A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 1 unknown_status NCT01506856
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial treatment 2 / 3 completed NCT05080556
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer treatment 2 recruiting NCT00039585
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor treatment 2 completed NCT00003385
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT04229615
A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy treatment 3 unknown_status NCT01083537
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction treatment 1 / 2 terminated NCT06173037
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer No drug interventions treatment 2 recruiting NCT00588237
Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer treatment 2 completed NCT00281632
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer treatment 2 completed NCT03759600
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer treatment 2 completed NCT00288275
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer No drug interventions Not Available Not Available terminated NCT02834975
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). treatment 2 terminated NCT00318370
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy treatment 2 completed NCT00006942
Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT04846842
A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer treatment 2 unknown_status NCT01144442
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer treatment Not Available terminated NCT02470299
Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients basic_science Not Available active_not_recruiting NCT01899599
PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer treatment 2 completed NCT01610206
A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer treatment 2 completed NCT00601406
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer No drug interventions treatment Not Available unknown_status NCT03783949
European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer treatment 2 completed NCT02487849
HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma treatment 2 withdrawn NCT02928549
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study No drug interventions Not Available Not Available completed NCT01204749
TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer treatment 3 completed NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00770536
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR treatment 1 completed NCT00520013
Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors treatment 2 completed NCT01216813
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer No drug interventions Not Available Not Available completed NCT00059618
PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer treatment 1 completed NCT01556841
The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer treatment 2 completed NCT06274541
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study No drug interventions Not Available Not Available active_not_recruiting NCT00006041
Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer No drug interventions treatment 1 completed NCT00616941
Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT01196741
Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer treatment 2 / 3 completed NCT00479817
Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT00017017
CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 1 / 2 completed NCT00373217
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 2 terminated NCT03540017
HIPEC After Initial CRS in Patients Who Have Received NACT treatment 1 recruiting NCT00003634
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy treatment 2 unknown_status NCT00004934
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 3 completed NCT00390234
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma treatment 2 completed NCT00003624
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer supportive_care 2 terminated NCT05538624
A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary treatment 1 / 2 terminated NCT01972516
Tivozanib As Maintenance Therapy In GYN treatment 2 terminated NCT00993616
Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin treatment 2 completed NCT04025216
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers treatment 1 terminated NCT06084416
A Study of Sovilnesib in Subjects With Ovarian Cancer No drug interventions treatment 1 recruiting NCT00003358
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT00905658
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer No drug interventions supportive_care 2 unknown_status NCT03373058
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery No drug interventions treatment 3 unknown_status NCT02349958
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy No drug interventions treatment 2 unknown_status NCT03921658
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer No drug interventions Not Available Not Available completed NCT01905163
Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients No drug interventions treatment 2 completed NCT05236686
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer No drug interventions treatment Not Available not_yet_recruiting NCT00466986
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer treatment 2 completed NCT06342986
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 1 recruiting NCT02324439
Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission No drug interventions prevention 1 completed NCT00096239
CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 2 completed NCT00897039
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer No drug interventions Not Available Not Available unknown_status NCT01766622
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant No drug interventions diagnostic 2 withdrawn NCT04227522
Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients treatment 3 active_not_recruiting NCT00669422
ChemoFx® PRO - A Post-Market Data Collection Study No drug interventions Not Available Not Available terminated NCT02534922
Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer treatment 1 unknown_status NCT00263822
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer treatment 3 completed NCT02728830
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers treatment 0 completed NCT05960630
MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer No drug interventions treatment Not Available recruiting NCT00903630
Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 1 / 2 terminated NCT00079430
Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT02884648
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery treatment 2 recruiting NCT00357448
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer treatment 1 completed NCT03693248
Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer treatment 3 unknown_status NCT05041257
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) treatment 2 active_not_recruiting NCT03983226
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) treatment 2 recruiting NCT01669226
First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer treatment 2 completed NCT02433626
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies treatment 1 unknown_status NCT04590326
A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 treatment 1 / 2 recruiting NCT00114166
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT05579366
PRO1184 for Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02480374
Study of Safety & Biological Activity of IP IMNN-001 (Also Known as GEN-1) With Neoadjuvant Chemo in Ovarian Cancer treatment 1 completed NCT05009082
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer treatment 3 recruiting NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors treatment 1 terminated NCT00004082
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors treatment 1 completed NCT05001282
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) No drug interventions treatment 1 / 2 terminated NCT00483782
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 3 completed NCT00538031
Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00989131
Study of Paclitaxel in Patients With Ovarian Cancer treatment 3 completed NCT00569673
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer treatment 2 completed NCT05574673
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype No drug interventions Not Available Not Available recruiting NCT00157573
GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer treatment 2 completed NCT00748527
Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 terminated NCT01188876
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer treatment 1 / 2 completed NCT01312376
Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer treatment 1 terminated NCT03355976
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas treatment 2 active_not_recruiting NCT03891576
Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer) treatment 2 active_not_recruiting NCT03332576
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer treatment 1 completed NCT05092360
Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) treatment 3 active_not_recruiting NCT00157560
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma No drug interventions treatment 2 completed NCT00003160
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum treatment 2 unknown_status NCT00002960
SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) treatment 1 completed NCT00634894
Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 withdrawn NCT00006391
Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT00032162
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer treatment 1 / 2 completed NCT01248962
Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 completed NCT00003380
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 1 terminated NCT00856180
Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies treatment 2 completed NCT00753480
A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer No drug interventions treatment 1 suspended NCT03648489
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) treatment 2 unknown_status NCT02725489
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers treatment 2 completed NCT02657889
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer treatment 1 / 2 completed NCT06087289
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 / 2 recruiting NCT03635489
A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT00421889
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment treatment 1 / 2 completed NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT02012192
GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer treatment 1 / 2 terminated NCT00501644
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer treatment 2 completed NCT01308944
Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients treatment 1 completed NCT02855944
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients treatment 3 completed NCT01666444
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 completed NCT03363867
BEACON - ABC in Recurrent Platinum Resistant HGSOC treatment 2 active_not_recruiting NCT01100372
Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 2 unknown_status NCT03159572
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations No drug interventions Not Available Not Available completed NCT00850772
Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer No drug interventions supportive_care 3 completed NCT00317772
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 completed NCT05199272
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT06161272
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi treatment 2 not_yet_recruiting NCT05912972
Development and Management of Registry in Patients With Gynecologic Cancer in Korea No drug interventions Not Available Not Available recruiting NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT00052468
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer treatment 3 completed NCT04027868
Genomic BRCA and Extensive ovArian Cancer Testing No drug interventions Not Available Not Available completed NCT01610869
Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer treatment 2 completed NCT00030446
Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT05080946
Using Aspirin to Improve Immunological Features of Ovarian Tumors treatment 0 recruiting NCT03522246
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy treatment 3 active_not_recruiting NCT00075712
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 / 3 completed NCT00428610
A Study of Chemotherapy Treatment for Patients With Ovarian Cancer treatment 2 completed NCT01253681
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer treatment 1 completed NCT00006981
Immunotoxin Therapy in Treating Patients With Advanced Cancer treatment 1 completed NCT04889495
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer Not Available Not Available not_yet_recruiting NCT00005095
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention No drug interventions Not Available Not Available recruiting NCT00672295
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer treatment 1 completed NCT00055614
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT04209855
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression treatment 3 active_not_recruiting NCT03607955
Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy treatment 1 withdrawn NCT03093155
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab treatment 2 completed NCT00217555
Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 completed NCT03480750
Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer treatment 1 / 2 completed NCT00866723
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer treatment 2 terminated NCT02915523
Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer treatment 1 / 2 completed NCT05665023
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma treatment 2 recruiting NCT03189108
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors No drug interventions Not Available Not Available completed NCT00008138
S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer treatment 2 completed NCT02859038
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) No drug interventions treatment 3 unknown_status NCT03657043
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) treatment 2 completed NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT04296890
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression treatment 3 completed NCT02121990
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer treatment 1 completed NCT06014190
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer No drug interventions treatment 2 recruiting NCT00459290
Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT05200364
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer treatment 1 active_not_recruiting NCT05065021
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor treatment 2 recruiting NCT02124421
HOT: HIPEC in Ovarian Cancer as Initial Treatment treatment 2 active_not_recruiting NCT06445621
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test No drug interventions Not Available Not Available recruiting NCT03393884
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) treatment 1 / 2 active_not_recruiting NCT05527184
First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers No drug interventions treatment 1 recruiting NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT00010179
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer treatment 2 completed NCT00059787
Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma treatment 2 completed NCT00053833
S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 terminated NCT05483933
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers treatment 1 active_not_recruiting NCT00006454
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer treatment 3 completed NCT01659554
A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers treatment 2 terminated NCT00031954
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT01391351
Search for Predictors of Therapeutic Response in Ovarian Carcinoma No drug interventions Not Available Not Available completed NCT01704651
Accelerating Gastrointestinal Recovery prevention 3 completed NCT00574951
AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 terminated NCT00189553
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse treatment 3 completed NCT01219777
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian treatment 1 completed NCT00091377
Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 / 2 completed NCT03180177
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer No drug interventions treatment 3 unknown_status NCT03924245
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers treatment 1 terminated NCT00005645
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment treatment 2 withdrawn NCT05329545
Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) treatment 3 terminated NCT03054298
CAR T Cells in Mesothelin Expressing Cancers No drug interventions treatment 1 completed NCT01669798
BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer treatment 2 completed NCT01074398
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 No drug interventions Not Available Not Available unknown_status NCT01493505
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer treatment 3 terminated NCT00033605
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis supportive_care 3 completed NCT01883297
"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions treatment 1 active_not_recruiting NCT06483997
Diet, Hepcidin, and Chemotherapy RDI No drug interventions Not Available Not Available recruiting NCT05801783
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer No drug interventions treatment 0 recruiting NCT01471483
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02278783
Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer treatment 2 terminated NCT04575961
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer treatment 2 recruiting NCT00505661
Letrozole in Patients With Ovarian Tumors treatment 2 terminated NCT04201561
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy prevention 3 active_not_recruiting NCT01091428
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer treatment 2 completed NCT01851928
Validation of a Nutrition Screening Tool No drug interventions Not Available Not Available completed NCT00275028
AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT02865811
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer treatment 2 completed NCT04204811
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy No drug interventions Not Available Not Available active_not_recruiting NCT00429793
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00418093
Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma treatment 2 terminated NCT00293293
Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine supportive_care Not Available completed NCT01402271
Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer treatment 1 / 2 completed NCT01137071
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer treatment 2 terminated NCT00381888
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer treatment 2 completed NCT03321188
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients treatment 2 recruiting NCT00303888
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 1 terminated NCT05887609
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib treatment 2 recruiting NCT00838656
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 unknown_status NCT00049556
Gefitinib in Treating Patients With Cervical Cancer treatment 2 completed NCT04375956
Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients treatment 2 recruiting NCT00287885
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer treatment 1 completed NCT05456685
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer treatment 2 active_not_recruiting NCT02661815
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer treatment 1 terminated NCT01482715
A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) treatment 1 / 2 completed NCT00436215
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer treatment 2 completed NCT00226915
Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma treatment 3 completed NCT05071937
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer treatment 2 recruiting NCT01166737
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer No drug interventions other Not Available completed NCT01079832
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies No drug interventions treatment 2 completed NCT01306032
Phase II ABT-888 With Cyclophosphamide treatment 2 completed NCT00019552
Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT00842452
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery treatment 1 completed NCT00478452
Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients treatment 1 completed NCT03430700
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer treatment 2 active_not_recruiting NCT00002600
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer treatment 1 completed NCT00910000
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer treatment 1 / 2 terminated NCT00692900
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer treatment 1 completed NCT03038100
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT05460000
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy No drug interventions treatment 2 not_yet_recruiting NCT01091259
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer treatment 2 completed NCT03188159
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer treatment 2 unknown_status NCT01196559
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer treatment 2 completed NCT00287859
Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 1 terminated NCT00045175
UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 1 completed NCT04814875
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy treatment 1 / 2 terminated NCT02452775
Autologous OC-L Vaccine and Ovarian Cancer No drug interventions treatment 1 terminated NCT05429970
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) prevention Not Available recruiting NCT00408070
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 terminated NCT00238342
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass No drug interventions diagnostic Not Available unknown_status NCT00138242
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer treatment 2 completed NCT00693342
Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission treatment 3 withdrawn NCT00230542
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer treatment 2 completed NCT00126542
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 completed NCT00702299
Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer treatment 1 completed NCT01670799
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer other 0 completed NCT01170299
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer No drug interventions supportive_care Not Available completed NCT00652899
Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 terminated NCT01447706
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers treatment 2 completed NCT02489006
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer treatment 2 active_not_recruiting NCT01582906
A Survivorship Care Plan for Gynaecological Cancer Patients No drug interventions Not Available Not Available completed NCT01649336
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer treatment 1 completed NCT00003636
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 3 completed NCT01968213
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) treatment 3 completed NCT02668913
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer No drug interventions diagnostic Not Available completed NCT00268918
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients treatment 1 completed NCT00652119
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin treatment 1 unknown_status NCT06545617
A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer treatment 1 / 2 not_yet_recruiting NCT00526617
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients treatment 1 completed NCT04676334
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib treatment 3 completed NCT00021034
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 1 completed NCT03311334
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT00003334
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract treatment 2 completed NCT05179824
Tempus Priority Study: A Pan-tumor Observational Study No drug interventions Not Available Not Available recruiting NCT05708924
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 1 suspended NCT03839524
A Trial Evaluating TG4050 in Ovarian Carcinoma. No drug interventions treatment 1 active_not_recruiting NCT00003896
S9912 Combination Chemo in Stage III Ovarian Cancer, treatment 2 completed NCT05377996
A Study of XMT-1660 in Participants With Solid Tumors No drug interventions treatment 1 recruiting NCT00267696
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 completed NCT00085358
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) treatment 1 completed NCT01035658
Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma treatment 1 / 2 terminated NCT02489058
A Study of Long-Term Responders on Olaparib No drug interventions Not Available Not Available completed NCT01296035
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer treatment 2 terminated NCT00058435
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 1 completed NCT00006235
Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT06451263
Nudge to Gynecologic Oncology No drug interventions supportive_care Not Available active_not_recruiting NCT03748186
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers treatment 1 completed NCT02435186
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer treatment 2 unknown_status NCT01370122
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies No drug interventions Not Available Not Available completed NCT00331422
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 terminated NCT00005025
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer treatment 2 unknown_status NCT02571725
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer treatment 1 / 2 active_not_recruiting NCT04368130
SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care No drug interventions supportive_care Not Available withdrawn NCT05870748
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 treatment 2 / 3 recruiting NCT00504257
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma treatment 2 completed NCT00112957
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT01663857
A Study LY2228820 for Recurrent Ovarian Cancer treatment 1 / 2 completed NCT02948426
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 1 terminated NCT04442126
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT00189566
Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse treatment 2 completed NCT03740165
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) treatment 3 active_not_recruiting NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT01276574
Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT No drug interventions Not Available Not Available active_not_recruiting NCT00003120
S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission treatment 3 completed NCT00801320
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer No drug interventions other Not Available completed NCT01570582
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 unknown_status NCT00003382
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer treatment 1 terminated NCT00959582
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) No drug interventions diagnostic 1 completed NCT04546373
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer Not Available Not Available completed NCT00617773
Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT04539327
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study Not Available Not Available completed NCT05256576
KORE-Innovation: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients With Ovarian Cancer No drug interventions health_services_research Not Available recruiting NCT02631876
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer treatment 3 completed NCT03367260
The Treatment Preferences of Women Diagnosed With Ovarian Cancer No drug interventions Not Available Not Available completed NCT00003560
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 unknown_status NCT05200260
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer treatment 2 not_yet_recruiting NCT00004060
Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT00466960
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy treatment 2 completed NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT00721162
Study of Ramucirumab in Ovarian Cancer treatment 2 completed NCT01065662
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies treatment 1 completed NCT02873962
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib treatment 2 active_not_recruiting NCT00041080
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 3 completed NCT00066729
Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT00217529
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer treatment 1 / 2 completed NCT00872989
S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 completed NCT01312389
A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 1 / 2 terminated NCT03000192
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life No drug interventions Not Available Not Available unknown_status NCT00343044
Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers treatment 2 completed NCT05537844
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma No drug interventions Not Available Not Available recruiting NCT00768144
Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma treatment 2 completed NCT00003944
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT01891344
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) treatment 2 completed NCT01262040
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive No drug interventions diagnostic Not Available completed NCT00562640
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) treatment 1 completed NCT00072267
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT01237067
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers treatment 1 completed NCT00086567
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers No drug interventions Not Available Not Available completed NCT06184867
Choices About Genetic Testing And Learning Your Risk With Smart Technology No drug interventions health_services_research 0 recruiting NCT00003967
Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT00182767
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer treatment 1 / 2 completed NCT00522301
Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission treatment 2 terminated NCT00354601
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer treatment 2 terminated NCT00436501
VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 1 / 2 completed NCT03824704
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) treatment 2 terminated NCT05198804
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer treatment 1 / 2 active_not_recruiting NCT00515372
Depression Treatment and Screening in Ovarian Cancer Patients No drug interventions treatment 1 active_not_recruiting NCT01591772
Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer No drug interventions Not Available Not Available completed NCT01661868
Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer treatment 2 withdrawn NCT00803569
Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers treatment 1 completed NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors treatment 1 completed NCT03126812
Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer treatment 1 / 2 completed NCT00028912
Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT00499512
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer No drug interventions Not Available Not Available unknown_status NCT00004012
Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00799110
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod treatment 2 active_not_recruiting NCT00322881
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer treatment 2 terminated NCT03593681
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy No drug interventions Not Available Not Available completed NCT01031381
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer treatment 2 completed NCT01096381
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor No drug interventions Not Available Not Available terminated NCT05739981
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 1 / 2 recruiting NCT06469281
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers treatment 1 recruiting NCT00002895
Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer No drug interventions treatment 3 completed NCT01146795
Neoadjuvant Therapy for Ovarian Cancer treatment 2 completed NCT03312114
Anti-PD-L1 and SAbR for Ovarian Cancer treatment 2 terminated NCT01048814
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases No drug interventions Not Available Not Available completed NCT01626014
Interactive Educational Website for Women With Ovarian Cancer & Caregivers No drug interventions supportive_care 0 completed NCT01281514
A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer treatment 1 completed NCT00993655
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer treatment 2 completed NCT02262455
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors treatment 1 completed NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies treatment 1 completed NCT00245050
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer supportive_care 3 completed NCT04983550
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC treatment 2 unknown_status NCT01105650
Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer treatment 2 completed NCT02973750
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer No drug interventions Not Available Not Available completed NCT04406623
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer No drug interventions treatment 1 completed NCT04001023
Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia No drug interventions treatment Not Available recruiting NCT00536523
Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions Not Available Not Available terminated NCT00061308
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer treatment 2 completed NCT00305838
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen diagnostic 2 unknown_status NCT00002538
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers No drug interventions treatment 2 completed NCT01416038
Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer treatment 1 completed NCT00028743
Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 3 completed NCT03283943
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers. treatment 1 unknown_status NCT03029403
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer treatment 2 active_not_recruiting NCT00637390
A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. treatment 1 terminated NCT00014690
ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 completed NCT00262990
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer treatment 3 completed NCT05261490
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer treatment 1 / 2 terminated NCT05622890
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer treatment 3 recruiting NCT00012090
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum treatment 2 completed NCT00004064
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 unknown_status NCT03213964
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int treatment 1 completed NCT03585764
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions treatment 1 terminated NCT00003064
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 / 2 unknown_status NCT02595021
Total/Subtotal Colectomy in Ovarian Cancer No drug interventions treatment 2 unknown_status NCT04598321
BrUOG 390: Neoadjuvant Treatment With Talazoparib treatment 1 terminated NCT03150121
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage No drug interventions diagnostic Not Available recruiting NCT00517621
Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire treatment 2 completed NCT01744821
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer No drug interventions prevention Not Available terminated NCT05043402
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer treatment 3 unknown_status NCT04537702
Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients No drug interventions supportive_care Not Available completed NCT03905902
DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma No drug interventions treatment 3 withdrawn NCT04515602
Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) No drug interventions treatment 3 not_yet_recruiting NCT00085384
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 terminated NCT05788484
A Study of CDX-585 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT00550784
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 1 completed NCT04510584
Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer treatment 2 withdrawn NCT01652079
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer treatment 2 completed NCT00543049
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor treatment 2 completed NCT02728622
Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane treatment 3 completed NCT00189358
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy treatment 2 completed NCT01104675
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer treatment 2 completed NCT01580696
Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer treatment 1 / 2 completed